Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 656,200 shares at $22.00 ($14.3M) on 2023-03-07, disclosed to the SEC on 2023-03-10.
Open-market purchase of $14.3M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.00 | 231,819 | $5.1M | 35.7% |
| 2 | $22.00 | 318,181 | $7.0M | 49.0% |
| 3 | $20.43 | 93,800 | $1.9M | 13.4% |
| 4 | $20.85 | 6,200 | $129K | 0.9% |
| 5 | $20.85 | 6,200 | $129K | 0.9% |
| Total | $21.75 avg | 656,200 |
| $14.3M |
| 100% |
| Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |
| RVMD | BUY | 2022-03-21 | $6.8M | — | Filing → |